Recurrent Melanoma
Oncology
Prevalence
75.0 / 100K
Incidence
23.0 / 100K/yr
3 drugs in development·1 company·5 clinical trials
Drug Pipeline by Phase
Compare drugs
Frequently asked questions
How many drugs are in development for Recurrent Melanoma?
BioSniper tracks 3 drugs in development for Recurrent Melanoma across 1 company.
How many clinical trials target Recurrent Melanoma?
There are 5 clinical trials targeting Recurrent Melanoma tracked by BioSniper.
What is the prevalence of Recurrent Melanoma?
The estimated prevalence of Recurrent Melanoma is approximately 75.0 per 100,000 population.
Deep-dive into Recurrent Melanoma
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis